Truist Financial Begins Coverage on Guardian Pharmacy Services
GRDN Stock | 24.28 0.66 2.65% |
About 56% of all Guardian Pharmacy's investors are looking to take a long position. The analysis of current outlook of investing in Guardian Pharmacy Services, suggests that some traders are interested regarding Guardian Pharmacy's prospects. Guardian Pharmacy's investing sentiment overview a quick insight into current market opportunities from investing in Guardian Pharmacy Services,. Many technical investors use Guardian Pharmacy stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Guardian |
Truist Financial started coverage on shares of Guardian Pharmacy Services in a research report issued on Monday, Briefing.com reports. The firm set a buy rating and a 22.00 price target on the stock. Truist Financials target price points to a potential upside of 24.43 percent from the stocks current price. Guardian
Read at thelincolnianonline.com
Guardian Pharmacy Fundamental Analysis
We analyze Guardian Pharmacy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Guardian Pharmacy is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Guardian Pharmacy Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardian Pharmacy stock to make a market-neutral strategy. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics with similar companies.
Peers
Guardian Pharmacy Related Equities
VMD | Viemed Healthcare | 3.69 | ||||
NVNO | EnVVeno Medical | 1.93 | ||||
TFX | Teleflex Incorporated | 0.76 | ||||
VRRM | Verra Mobility | 0.51 | ||||
GOLD | Barrick Gold | 0.97 | ||||
PAL | Proficient Auto | 3.07 |
Check out Guardian Pharmacy Hype Analysis, Guardian Pharmacy Correlation and Guardian Pharmacy Performance. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.